Drug Dealing and Grand Theft – Now Legal 




Drop in stock price

For the 7 months during 2016 that he was CEO of Valeant Pharmaceuticals, Joseph Papa was paid $62.7 million.

Papa started in May of last year. During his tenure in 2016, Valeant's stock price fell 55%, the company lost $2.4 billion and revenue declined 7.4%.

— Source: 


Leave a Reply

Your email address will not be published. Required fields are marked *

Best comments get a free hardcover copy of Living Sanely in an Insane World. We'll email you for your address if you're selected.